Surgery Partners, Inc. (NASDAQ:SGRY) Insider Sells $76,028.04 in Stock

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the sale, the insider now directly owns 63,408 shares of the company's stock, valued at approximately $1,527,498.72. The trade was a 4.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Surgery Partners Trading Up 1.4 %

Shares of NASDAQ:SGRY traded up $0.33 during midday trading on Monday, reaching $23.93. The company's stock had a trading volume of 149,200 shares, compared to its average volume of 1,065,298. The firm has a market capitalization of $3.05 billion, a price-to-earnings ratio of -49.84, a PEG ratio of 19.21 and a beta of 2.73. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The firm has a 50 day moving average price of $23.58 and a two-hundred day moving average price of $25.99. Surgery Partners, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.01. The company had revenue of $864.40 million for the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. As a group, analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Remove Ads

Analyst Ratings Changes

SGRY has been the topic of several recent analyst reports. Macquarie decreased their price target on Surgery Partners from $34.00 to $33.00 and set an "outperform" rating on the stock in a research note on Tuesday, March 11th. Bank of America initiated coverage on Surgery Partners in a research note on Monday, December 16th. They issued a "buy" rating and a $30.00 price target on the stock. Royal Bank of Canada reduced their price objective on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research report on Wednesday, November 20th. Finally, JPMorgan Chase & Co. reduced their price objective on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $36.63.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Mackenzie Financial Corp raised its stake in Surgery Partners by 2.8% during the 4th quarter. Mackenzie Financial Corp now owns 21,974 shares of the company's stock worth $465,000 after buying an additional 599 shares during the period. Two Sigma Investments LP raised its stake in Surgery Partners by 93.6% during the 4th quarter. Two Sigma Investments LP now owns 43,338 shares of the company's stock worth $917,000 after buying an additional 20,949 shares during the period. Troluce Capital Advisors LLC bought a new stake in Surgery Partners during the 4th quarter worth approximately $8,662,000. State of Wyoming increased its holdings in Surgery Partners by 94.4% during the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock worth $85,000 after purchasing an additional 1,943 shares in the last quarter. Finally, Silvercrest Asset Management Group LLC increased its holdings in Surgery Partners by 44.9% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 998,505 shares of the company's stock worth $21,138,000 after purchasing an additional 309,481 shares in the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.